about
Engineering of TEV protease variants by yeast ER sequestration screening (YESS) of combinatorial librariesAutoactivation of Thrombin PrecursorsStructure-Based Design and Synthesis of a New Phenylboronic-Modified Affinity Medium for Metalloprotease Purification.Basis for substrate recognition and distinction by matrix metalloproteinasesA system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutationsA protease substrate profiling method that links site-specific proteolysis with antibiotic resistance.Allostery in trypsin-like proteases suggests new therapeutic strategies.Conformational selection in trypsin-like proteases.Therapeutic control of complement activation at the level of the central component C3.Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.Overview of scorpion species from China and their toxins.Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host.Research applications of proteolytic enzymes in molecular biology.Microbial aspartic proteases: current and potential applications in industry.Synergistic Caseinolytic Activity and Differential Fibrinogenolytic Action of Multiple Proteases of Maclura spinosa (Roxb. ex Willd.) latex.Protein engineering: a new frontier for biological therapeutics.Matrix metalloproteinases as reagents for cell isolation.Emerging technologies for protease engineering: New tools to clear out disease.Rational design and synthesis of affinity matrices based on proteases immobilized onto cellulose membranes.Proteolytic activity in the meibomian gland: Implications to health and disease.Cold-adapted proteases as an emerging class of therapeutics.Rapid and efficient one-step purification of a serralysin family protease by using a p-aminobenzamidine-modified affinity medium.Inflammation induced by phytomodulatory proteins from the latex of Calotropis procera (Asclepiadaceae) protects against Salmonella infection in a murine model of typhoid fever.A New Subtilase-Like Protease Deriving from Fusarium equiseti with High Potential for Industrial Applications.Engineering trypsin for inhibitor resistance.MFPred: Rapid and accurate prediction of protein-peptide recognition multispecificity using self-consistent mean field theory.Rational Design of Recombinant Papain-Like Cysteine Protease: Optimal Domain Structure and Expression Conditions for Wheat-Derived Enzyme Triticain-α.Phage-assisted continuous evolution of proteases with altered substrate specificity.Cloning, Expression, and Functional Characterization of Serine Protease Aprv2 from Virulent Isolate Dichelobacter nodosus of Indian Origin.Affinity purification of metalloprotease from marine bacterium using immobilized metal affinity chromatography.Engineering β-lactamase zymogens for use in protease activity assays.Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein.N-glycosylation in the protease domain of trypsin-like serine proteases mediates calnexin-assisted protein folding.Multiple domains of bacterial and human Lon proteases define substrate selectivity
P2860
Q24630061-187D08ED-30FF-4C5A-9096-E3DA8721ABC9Q27676718-673D5B2B-BD07-47FA-9BFD-5BBDCC4FDD32Q30378977-F123012E-F6E8-464E-981C-B283D05134A9Q34407655-13FD812A-57C5-4E08-81DE-9BADCD36DF62Q34430652-51535109-2DC1-4406-A881-7B802FD0CB1AQ35045326-4927643B-E98B-4E41-B05F-F272BDCAAD97Q35317139-4333D33E-C822-4A53-888B-39487C5B24ECQ36177002-16E2DEC6-BE6C-4F77-A4A0-DBC4ECABE4CBQ36363005-B70CF92C-DA6E-406A-83B0-BA206BB1F50CQ36991412-EED3C806-54C5-42BA-81B6-C58E6B71E5FFQ37670009-48F8B0C0-C657-4D1E-9B7B-22FDBC791A55Q38005762-0B0317FE-C5A3-45EA-B4BB-24E593AFB592Q38223683-D02E6620-09D9-4CD6-8FE7-C5F849A38CA4Q38255606-E4679D61-0651-4D70-B146-CC25895BD6B1Q38282275-DF932589-4D36-4FD3-8F6F-3271F2D49F26Q38286271-4B24E70E-FC67-4164-A90F-B14C1D8B033BQ38435741-2770F632-5663-4B5A-8B4A-40D7E9D927B7Q38833850-8F419DFA-603B-4972-B79B-A3CB99EE77D4Q38840826-650D3546-CC32-4432-BC54-E08409701D20Q39174470-41450C14-835C-4F20-A086-F1C4931C895DQ39410680-2FFCEC04-843E-4F73-A4AE-CFB56F726D69Q40290219-D4C31334-7175-465F-949A-85795DBDA5BDQ40290854-2F1903F4-41DD-44D1-A44B-184F2D6A9825Q40732288-518C63EF-8E40-46E4-85C0-750F77856E56Q40803596-4CFA8D5F-4D1E-4E21-A193-B3A9CF573937Q40995571-883B9774-C47D-405F-BFD3-F69B2783F4BFQ41181668-A49C64E8-A945-4E3E-B168-31D8E451AFE5Q42378984-37A8ACE9-E3C6-42D8-A7D9-5ED0731FB498Q50202046-91563E54-3553-4CAC-BD9B-820E89DF22B3Q51383031-2729BF30-6029-41CF-9B39-29F7C3A4422CQ53494747-46B40A9C-5F69-4F62-9C62-B0B82C01BB44Q55209557-05AFB7CA-F3F8-4072-B64F-B0424CD6D7FDQ55426082-1AAACF28-0A9D-4061-9A9C-2F7B21809576Q58770991-28848A00-8D9E-4420-917A-C03D2ACBC768
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteases as therapeutics.
@en
Proteases as therapeutics.
@nl
type
label
Proteases as therapeutics.
@en
Proteases as therapeutics.
@nl
prefLabel
Proteases as therapeutics.
@en
Proteases as therapeutics.
@nl
P2093
P2860
P356
P1433
P1476
Proteases as therapeutics.
@en
P2093
Charles S Craik
Edwin L Madison
Michael J Page
P2860
P356
10.1042/BJ20100965
P407
P577
2011-04-01T00:00:00Z